New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For GE;DELL;GSK;AZN;BEN;AAPL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 >>
August 24, 2015
13:42 EDTAAPLApple goes negative on the session, levels to watch
Subscribe for More Information
13:15 EDTGSKFDA expands use of Novartis' Promacta to include children ages 1 and older
Ligand Pharmaceuticals (LGND) announced that the FDA has approved an expanded use for Promacta, a Novartis (NVS) product, to include children 1 year of age and older with chronic immune thrombocytopenia who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. Promacta was acquired by Novartis in March from GlaxoSmithKline (GSK). Promacta was discovered as a result of research collaboration between GSK and Ligand Pharmaceuticals and was developed by GSK. The updated label also includes a new oral suspension formulation of Promacta that is designed for younger children who may not be able to swallow tablets. Promacta was approved by the FDA as a tablet formulation in June 2015 for children 6 years of age and older and in 2008 for use in adult patients with the same condition. The label expansion of Promacta was based on data from two double-blind, placebo-controlled trials, including the largest Phase 3 clinical trial in this patient population. Treatment with Promacta significantly increased and sustained platelet counts among pediatric patients with chronic ITP with an insufficient response to prior chronic ITP therapies, and some patients taking concomitant ITP medications were able to reduce or discontinue their use of these medications, primarily corticosteroids. Promacta should be used only in those whose degree of thrombocytopenia and clinical condition increase the risk for bleeding.
12:17 EDTAAPLOn The Fly: Top stock stories at midday
Subscribe for More Information
11:46 EDTAAPLApple turns positive on the session
Subscribe for More Information
11:05 EDTAAPLStocks with call strike movement; FB AAPL
Subscribe for More Information
10:23 EDTAAPLApple continues to edge up off earlier lows
Subscribe for More Information
10:12 EDTAAPLApple China concerns 'way overblown,' says Cantor
Cantor Fitzgerald analyst Brian White attributes the slide in Apple shares to growing fears regarding China, but White believes those concerns have been "way overblown" and have pushed the stock to a "severely depressed" valuation. Even if EPS estimates for calendar year 2016 are only 50% of the firm's current projection, the stock is trading at a multiple of "just 14.5x" that projection, notes White, who "highly" doubts that even a global recession would drive Apple's results to slide that far. White reiterates a Buy rating and $195 price target on shares of Apple, which are down 2% to $103.65 in early trading this morning.
09:44 EDTAAPLApple drops sharply, cuts losses
Subscribe for More Information
09:36 EDTAAPLActive equity options trading on open
Active equity options trading on open: AAPL FB BAC NFLX
09:27 EDTAAPLApple CEO says business in China strong through July, August
Subscribe for More Information
09:18 EDTAAPLOn The Fly: Pre-market Movers
Subscribe for More Information
09:15 EDTAAPLApple drops in pre-market
Subscribe for More Information
08:27 EDTAAPLApple volatility elevated
Apple August weekly call option implied volatility is at 54, September is at 45, October is at 41; compared to its 52-week range of 15 to 36; suggesting large near term price movement.
06:27 EDTAAPLRoku tops Google in streaming media device sales, Parks Associates says
Subscribe for More Information
06:22 EDTAAPLTSMC pursuing 16nm chip orders, DigiTimes reports
According to market sources, DigiTimes reports that TSMC (TSM) has been "actively" seeking 16nm FinFET chip orders. In addition to securing a portion of Apple's (AAPL) A9 chip orders, TSMC has also received orders from AMD (AMD), Broadcom (BRCM), LG, Nvidia (NVDA) and Avago (AVGO), the sources say, noting that TSMC failed to maintain orders for Qualcomm's (QCOM) flagship mobile chips, as it has placed orders for the Snapdragon 820 series with Samsung (SSNLF). Reference Link
06:18 EDTAAPLApple announces repair program for blurry iPhone 6 Plus cameras
Subscribe for More Information
05:45 EDTAAPLStocks with implied volatility movement; AAPL EFA
Subscribe for More Information
05:13 EDTAZNAstraZeneca to collaborate with Peregrine on cancer immunotherapy clinical trial
Subscribe for More Information
August 23, 2015
19:03 EDTAAPLApple hires Tesla engineer for 'special projects' division
Subscribe for More Information
14:23 EDTAAPLApple, Micron shares look like bargains, Barron's says
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use